3//SEC Filing
Dainippon Sumitomo Pharma Co Ltd 3
Accession 0000899243-21-038643
CIK 0001635088other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:00 PM ET
Size
6.2 KB
Accession
0000899243-21-038643
Insider Transaction Report
Form 3
Dainippon Sumitomo Pharma Co Ltd
10% Owner
Holdings
- 86,367,360(indirect: See Footnote)
Common Shares
Sumitomo Chemical Co., Ltd.
10% Owner
Holdings
- 86,367,360(indirect: See Footnote)
Common Shares
Footnotes (1)
- [F1]Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon") directly owns 86,367,360 Common Shares. Sumitomo Dainippon is a 51.78% owned subsidiary of Sumitomo Chemical Co., Ltd. ("Sumitomo"). Sumitomo may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) the reported securities that Sumitomo Dainippon owns. Sumitomo disclaims beneficial ownership of such reported securities except to the extent of its pecuniary interest therein.
Documents
Issuer
Roivant Sciences Ltd.
CIK 0001635088
Entity typeother
IncorporatedJapan
Related Parties
1- filerCIK 0001446601
Filing Metadata
- Form type
- 3
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 5:00 PM ET
- Size
- 6.2 KB